01 1LG Chem Corp.
01 1LG Chem Corp.
01 1Gemifloxacin mesylate
01 1South Korea
Registrant Name : LG Chem Corp.
Registration Date : 2022-10-11
Registration Number : 20221011-209-J-1375
Manufacturer Name : LG Chem Corp.
Manufacturer Address : 129 Seokam-ro, Iksan-si, Jeonbuk Special Self-Governing Province
64
PharmaCompass offers a list of Gemifloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Gemifloxacin manufacturer or Gemifloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gemifloxacin manufacturer or Gemifloxacin supplier.
A Factive manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Factive, including repackagers and relabelers. The FDA regulates Factive manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Factive API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Factive manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Factive supplier is an individual or a company that provides Factive active pharmaceutical ingredient (API) or Factive finished formulations upon request. The Factive suppliers may include Factive API manufacturers, exporters, distributors and traders.
click here to find a list of Factive suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Factive Drug Master File in Korea (Factive KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Factive. The MFDS reviews the Factive KDMF as part of the drug registration process and uses the information provided in the Factive KDMF to evaluate the safety and efficacy of the drug.
After submitting a Factive KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Factive API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Factive suppliers with KDMF on PharmaCompass.
